CRIS Current Research Information System

CAPPELLINI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.057
EU - Europa 2.470
AS - Asia 1.177
AF - Africa 142
SA - Sud America 8
OC - Oceania 5
Totale 6.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.048
GB - Regno Unito 560
IT - Italia 509
SE - Svezia 412
CN - Cina 385
DE - Germania 329
VN - Vietnam 296
SG - Singapore 293
RU - Federazione Russa 122
IN - India 118
IE - Irlanda 98
UA - Ucraina 88
FR - Francia 84
TG - Togo 55
FI - Finlandia 50
EE - Estonia 46
ZA - Sudafrica 42
CH - Svizzera 38
BG - Bulgaria 36
JO - Giordania 32
CI - Costa d'Avorio 27
BE - Belgio 25
AT - Austria 20
IR - Iran 16
ID - Indonesia 11
NG - Nigeria 11
NL - Olanda 10
CA - Canada 9
HR - Croazia 8
JP - Giappone 7
SC - Seychelles 7
GR - Grecia 6
HK - Hong Kong 6
PT - Portogallo 6
CZ - Repubblica Ceca 5
PL - Polonia 5
BR - Brasile 4
AU - Australia 3
CL - Cile 3
KR - Corea 3
SK - Slovacchia (Repubblica Slovacca) 3
TR - Turchia 3
LT - Lituania 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
NO - Norvegia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.859
Salva come PNG Salva come JPEG
Città #
Southend 481
Chandler 324
Fairfield 271
Singapore 254
Santa Clara 223
Ashburn 221
Houston 197
Ann Arbor 194
Woodbridge 162
Bologna 153
Dong Ket 150
Seattle 148
Wilmington 130
Princeton 113
Dublin 98
Cambridge 96
Boardman 86
Lomé 55
Nanjing 51
Padova 51
Helsinki 50
Westminster 50
Jacksonville 49
New York 46
Sofia 36
Berlin 35
Bern 34
Amman 32
Bremen 29
Redmond 28
Shenyang 28
Abidjan 27
Saint Petersburg 25
Turin 25
Brussels 24
Milan 22
San Diego 22
Beijing 21
Florence 21
Changsha 20
Jinan 20
Frankfurt am Main 18
Tianjin 16
Vienna 16
Guangzhou 15
Moscow 15
Nanchang 15
Falkenstein 14
Hebei 14
Los Angeles 14
Rome 13
Hangzhou 12
Medford 12
Abeokuta 11
Des Moines 11
Falls Church 11
Redwood City 11
Verona 11
Zhengzhou 11
Mülheim 10
Norwalk 10
Ferrara 9
Jakarta 9
Parma 9
London 8
Ningbo 8
Shanghai 8
Bühl 7
Mahé 7
Nuremberg 7
Olalla 7
Tappahannock 7
Udine 7
Washington 7
Dearborn 6
Hong Kong 6
Jiaxing 6
Mountain View 6
Phoenix 6
Pune 6
Toronto 6
Chicago 5
Haikou 5
Tokyo 5
Yubileyny 5
Amsterdam 4
Andover 4
Boydton 4
Dongguan 4
Lisbon 4
Maranello 4
Modena 4
Paris 4
Taizhou 4
Villacidro 4
Buffalo 3
Cento 3
Forlì 3
Frankfurt Am Main 3
Fremont 3
Totale 4.579
Salva come PNG Salva come JPEG
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 257
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. 192
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 189
Therapeutic targeting of CK2 in acute and chronic leukemias. 155
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 149
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 147
Improving nelarabine efficacy in T-cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway. 141
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 140
Specific presence of PKC isoforms in low and fast proliferation Moris hepatoma cells 140
Application of flow cytometry to molecular medicine: Detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts 137
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 136
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device 134
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 133
Effect of PKC inhibition on low and fast proliferating Morris rat hepatoma cell line progression 131
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 131
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 130
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. 128
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 127
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 126
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. 123
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 123
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS 122
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 122
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation 122
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 122
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells 120
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 120
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of LGR5 and Notch1 Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine 120
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage 118
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES 118
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 118
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 116
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 116
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 115
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 115
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 115
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 113
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 112
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 111
Metabolism and signaling activities of nuclear lipids 110
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. 109
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 108
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism 108
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 105
Targeting Wnt/beta-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. 100
null 95
PKC inhibitors induced apoptosis in Morris hepatoma 92
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 90
The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. 87
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways 84
SELECTIVE EFFECT OF LENALIDOMIDE ON CELL CYCLE AND INOSITIDE-DEPENDENT ERYTHROID SIGNALLING IN DEL(5Q) CELLS AND MYELODYSPLASTIC SYNDROMES (MDS) 84
null 75
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES 75
null 61
null 61
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 59
Improving nelarabine efficacy in refractory/relapsed T-cell Acute Lymphoblastic Leukemia by targeting aberrant PI3K/mTOR signaling 58
null 45
INHIBITION OF PROLIFERATION AND SURVIVAL IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) CELLS REQUIRES BLOCKADE OF ALL THE CLASS I PI3Ks ISOFORMS 42
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 35
Nuclear translocation of PKC-alpha is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 34
Flow cytometric detection of total and serine 473 phosphorylated Akt 27
HIV-1 Tat Protects CD4+ Jurkat T Lymphoblastoid Cells from Apoptosis Mediated by TNF-Related Apoptosis-Inducing Ligand 24
Molecular characterization of protein kinase C‐α binding to lamin A 20
Intranucleolar localization of DNA topoisomerase IIα is a distinctive feature of necrotic, but not of apoptotic, Jurkat T‐cells 17
The controversial nuclear matrix: a balanced point of view 14
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-κB activation and cFLIPL up-regulation 13
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27Kip1 and control of cyclin D1 expression 13
Diacylglycerol kinase-θ is localized in the speckle domains of the nucleus 13
Supravital exposure to propidium iodide identifies apoptosis on adherent cells 10
Totale 7.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020569 0 0 0 0 0 0 0 144 211 82 63 69
2020/2021891 156 53 27 19 20 45 34 55 62 45 46 329
2021/20221.360 154 17 95 125 108 67 51 87 43 225 218 170
2022/20231.368 117 183 69 191 111 126 63 67 240 18 104 79
2023/2024527 35 58 44 52 34 128 19 47 25 31 24 30
2024/20251.037 42 185 144 84 341 86 95 60 0 0 0 0
Totale 7.052